Latest Bristol-Myers Squibb Stories
LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Researchers have identified the first genetic variations linked to race that begin to explain a higher risk of death among some African American and Caucasian patients taking the anti-clotting drug clopidogrel (Plavix) after a heart attack.
LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
JACKSONVILLE, Florida, June 17, 2014 /PRNewswire/ -- NGA Human Resources, a leader in Global HR and Payroll, today announced it has been selected by global biopharmaceutical
Health Canada has reinstated Biolyse Pharma’s Establishment Licence (EL) after sending in a team of inspectors to look at manufacturing within the St.Catharines based Pharmaceutical.
YARDLEY, Pa., June 12, 2014 /PRNewswire/ -- OptiNose, a global specialty pharmaceuticals company, today announced three appointments to the Company's senior management team.
LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
LONDON, June 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a combination therapy of the drugs vermurafenib, cetuximab and irinotecan.
Phase 1 Study Evaluating Talimogene Laherparepvec Plus Ipilimumab Showed Tolerability at Doses Administered THOUSAND OAKS, Calif., June 2, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN)
- The act of sweetening by admixture of some saccharine substance.